Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.37	8.61	24.4	89.48	110.95	207.23
Cash & Short-Term Investments	8.37	8.61	24.4	89.48	110.95	207.23
Cash Growth	-91.35%	-64.73%	-72.73%	-19.35%	-46.46%	23.25%
Accounts Receivable	131.95	69.84	60.36	35	21.74	50.17
Other Receivables	5.78	5.24	3.35	2.49	1.58	258.78
Receivables	137.73	75.07	63.71	37.49	23.32	308.95
Inventory	126.95	102.05	95.83	109.31	144.97	79.61
Prepaid Expenses	-	8.87	0.34	0.01	-	-
Other Current Assets	44.5	19.64	14.42	15.57	32.91	123.54
Total Current Assets	317.54	214.24	198.7	251.86	312.16	719.32
Property, Plant & Equipment	1,750	1,808	1,872	2,198	2,231	1,863
Long-Term Investments	-	-	710.41	672.17	652.02	646.34
Other Intangible Assets	64.12	67.14	74.31	79.3	52.53	53.82
Long-Term Deferred Tax Assets	4.71	4.55	3.05	2.9	6.09	9.88
Long-Term Deferred Charges	5.72	5.07	6.23	6.8	7.65	8.19
Other Long-Term Assets	83.69	67.99	92.81	67.53	44.37	33.69
Total Assets	2,226	2,167	2,958	3,279	3,306	3,335
Accounts Payable	832.7	820.22	635.36	692.24	567.22	414.53
Accrued Expenses	46.09	143.15	123.87	18.58	24.6	12.99
Short-Term Debt	586.49	674.32	532.24	461.67	344.19	497.38
Current Portion of Long-Term Debt	1.27	-	424.53	369.54	74.2	-
Current Portion of Leases	-	1.66	1.23	0.75	0.32	-
Current Income Taxes Payable	11.64	-	-	0.74	0.02	1.8
Current Unearned Revenue	4.63	3.27	8.05	4.18	56.45	1.11
Other Current Liabilities	512.38	254.87	155.78	18.83	13.04	214.61
Total Current Liabilities	1,995	1,898	1,881	1,567	1,080	1,142
Long-Term Debt	250	-	743.8	781.5	1,079	850
Long-Term Leases	1.33	1.29	1.7	1.53	1.86	-
Long-Term Unearned Revenue	17.27	17.63	18.26	19.9	12.91	9.96
Long-Term Deferred Tax Liabilities	2.2	2.52	3.06	3.2	3.65	6.85
Other Long-Term Liabilities	1.57	7.91	3.96	11.97	64.47	52.43
Total Liabilities	2,268	1,927	2,652	2,385	2,242	2,062
Common Stock	684.88	684.88	684.88	684.88	684.88	684.88
Additional Paid-In Capital	957.74	957.74	442.27	442.04	441.79	463.52
Retained Earnings	-1,822	-1,571	-1,032	-497.71	-356.23	-190.14
Comprehensive Income & Other	-	-	3.93	0.1	-0.12	-2.11
Total Common Equity	-179.19	71.79	99.16	629.31	770.32	956.15
Minority Interest	137.67	168.37	206.5	264.77	293.4	316.75
Shareholders' Equity	-41.51	240.17	305.65	894.08	1,064	1,273
Total Liabilities & Equity	2,226	2,167	2,958	3,279	3,306	3,335
Total Debt	839.09	677.27	1,704	1,615	1,500	1,347
Net Cash (Debt)	-830.72	-668.67	-1,679	-1,526	-1,389	-1,140
Net Cash Per Share	-1.21	-0.98	-2.45	-2.23	-2.03	-1.69
Filing Date Shares Outstanding	684.88	684.88	684.88	684.88	684.88	684.88
Total Common Shares Outstanding	684.88	684.88	684.88	684.88	684.88	684.88
Working Capital	-1,678	-1,683	-1,682	-1,315	-767.88	-423.1
Book Value Per Share	-0.26	0.10	0.14	0.92	1.12	1.40
Tangible Book Value	-243.3	4.65	24.84	550.01	717.79	902.33
Tangible Book Value Per Share	-0.36	0.01	0.04	0.80	1.05	1.32
Buildings	-	643.45	669.89	767.23	607.44	305.07
Machinery	-	1,579	1,521	1,623	1,078	207.05
Construction In Progress	-	79.43	72.79	74.65	696.41	1,464

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.